TP53 and neoplasm: Notably, a study on Myc-induced lymphoma demonstrated that inhibiting autophagy, either through chloroquine or ATG5 shRNA, augmented the impact of p53 activation and alkylating drug therapies, leading to enhanced tumor cell apoptosis.